Yes, buprenorphine causes constipation. It is one of the most common side effects of the medication, whether you’re taking it for pain management or opioid use disorder. Because buprenorphine is a partial opioid, it generally produces less constipation than full opioids like morphine or codeine, but the effect is real and, for many people, persistent.
Why Buprenorphine Slows Your Gut
Your digestive tract has its own network of opioid receptors, separate from the ones in your brain. When buprenorphine activates these receptors, it triggers a chain of changes: your intestines absorb more fluid than usual, secrete less fluid into the digestive space, and the muscles that push food along contract less forcefully. The net result is that stool moves through your colon much more slowly, loses more water along the way, and becomes hard and difficult to pass.
Buprenorphine also gets broken down in your body into a metabolite called norbuprenorphine. Unlike buprenorphine itself, which is a partial activator of opioid receptors, norbuprenorphine is a full activator. Research suggests this metabolite plays a significant role in gut-related side effects, contributing to the overall slowdown of digestive processes even when buprenorphine’s own effects on the gut are relatively mild.
How It Compares to Other Opioids
Buprenorphine’s partial opioid activity gives it an advantage here. A large retrospective study of patients with non-cancer pain in England found that buprenorphine had a lower incidence rate of severe constipation events compared to codeine, and a statistically non-significant but lower risk overall. Full opioids like morphine and oxycodone tend to cause more pronounced constipation because they fully activate the receptors in the gut wall.
That said, “less constipation than morphine” doesn’t mean no constipation. Methadone, another medication used for opioid use disorder, lists constipation as a common side effect alongside sedation, nausea, and sweating. In a preliminary comparison of methadone and buprenorphine patients, self-reported side effects were broadly similar between the two groups, though methadone carries additional risks like heart rhythm changes that buprenorphine does not.
Higher Doses Mean Greater Risk
Constipation from opioids, including buprenorphine, is dose-dependent. In the English cohort study, patients taking opioid doses equivalent to 50 or more morphine milligrams per day had roughly double the risk of severe constipation compared to those on lower doses. The vast majority of buprenorphine patients in the study (about 90%) were on doses below that threshold, which partly explains the medication’s comparatively favorable constipation profile. But if your dose increases, your constipation risk rises with it.
It Doesn’t Get Better on Its Own
Unlike nausea or drowsiness, which many opioid users adjust to within the first few weeks, constipation is one side effect where your body rarely develops tolerance. A survey published in Pain Medicine found that opioid-induced constipation does not resolve over time for most patients. If buprenorphine is causing you constipation in the first month, you can expect it to continue as long as you’re taking the medication. This makes proactive management important rather than waiting it out.
When Constipation Becomes a Clinical Problem
Not every change in bowel habits qualifies as a medical issue. The standard diagnostic framework considers constipation clinically significant when you experience at least two of the following for three months or longer:
- Fewer than three bowel movements per week
- Hard stools in at least a quarter of your bowel movements
- Straining during at least a quarter of bowel movements
- A feeling of incomplete evacuation at least a quarter of the time
- Needing to use manual measures to pass stool
If you recognize yourself in two or more of those criteria, you’re dealing with something beyond occasional irregularity.
Managing Buprenorphine-Related Constipation
The first line of defense is straightforward lifestyle adjustment. Aiming for 25 to 30 grams of soluble fiber daily (from sources like oats, beans, fruits, and vegetables or a fiber supplement), drinking adequate water throughout the day, and staying physically active all help keep things moving. Avoiding heavy, high-fat meals can also reduce the burden on a sluggish digestive system.
When lifestyle changes aren’t enough, osmotic laxatives are the standard next step. Polyethylene glycol (sold as MiraLAX and similar brands) is generally preferred because it draws water into the colon and softens stool without causing harsh cramping. Stimulant laxatives, which directly trigger intestinal muscle contractions, are another option and can be combined with osmotic laxatives when needed.
For people who don’t get adequate relief from conventional laxatives, a class of medications designed specifically for opioid-induced constipation exists. These drugs block opioid receptors in the gut without crossing into the brain, so they relieve constipation without interfering with buprenorphine’s intended effects. They’re typically reserved for cases where standard approaches have failed, and your prescriber can determine whether they’re appropriate for your situation.
Sublingual vs. Injectable Forms
Buprenorphine comes in several formulations: sublingual tablets and films, buccal films, transdermal patches, and long-acting monthly injections. Because all of these deliver buprenorphine into your bloodstream (and all produce norbuprenorphine as a metabolite), the constipating effect is present regardless of how you take the medication. The route of administration changes how quickly the drug reaches peak levels and how steadily it’s released, but the fundamental interaction with gut opioid receptors remains the same. No formulation has been shown to eliminate constipation as a side effect.